Could GLP-1 medications like Ozempic, Wegovy, Mounjaro, and Zepbound be far more than weight-loss drugs?

In this special bonus episode of Greta Wire, Greta Van Susteren is joined by Dr. Jen Ashton on NEWSMAX TV’s The Record with Greta Van Susteren to discuss a new study suggesting GLP-1 drugs may be associated with reduced cancer progression in several obesity-related cancers.

Dr. Ashton explains what the study found, what it does — and does not — prove, and why researchers are now looking at GLP-1 medications for possible effects on inflammation, the immune system, cancer spread, recurrence, and prevention. Greta also presses on the insurance question: if these drugs may help prevent expensive and devastating medical complications, why do insurers often resist paying for them upfront?

Plus, Greta asks whether the anti-inflammatory effects of GLP-1s could someday help people suffering from arthritis.

Watch this timely bonus conversation from Greta Wire and The Record with Greta Van Susteren.